SHORT-TERM ADHERENCE OF URATE-LOWERING AGENTS WILL NOT IMPROVE END-STAGE RENAL DISEASE AND MORTALITY

    Research output: Contribution to journalJournal Article peer-review

    Original languageAmerican English
    Pages (from-to)446-447
    JournalAnnals of the Rheumatic Diseases
    Volume79
    DOIs
    StatePublished - 2020

    Cite this